Inovio Pharmaceuticals Historical PE Ratio image   This INO PE ratio history page last updated 3/25/2024
Inovio Pharmaceuticals Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/6/2024
9.87-1.10-4.40NA
Q3 2023
11/9/2023
4.32-1.56-6.24NA
Q2 2023
8/9/2023
4.80-1.56-6.24NA
Q1 2023
5/10/2023
9.72-1.92-7.68NA
Q4 2022
3/1/2023
14.88-2.64-10.56NA
Q3 2022
11/8/2022
25.68-1.80-7.20NA
Q2 2022
8/9/2022
25.20-5.52-22.08NA
Q1 2022
5/10/2022
29.88-4.32-17.28NA
Q4 2021
3/1/2022
38.88-6.00-24.00NA
Q3 2021
11/9/2021
84.60-3.48-13.92NA
Q2 2021
8/9/2021
115.20-4.68-18.72NA
Q1 2021
5/10/2021
80.04-3.24-12.96NA
Q4 2020
3/1/2021
139.20-1.68-6.72NA
Q3 2020
11/9/2020
102.00-3.12-12.48NA
Q2 2020
8/10/2020
227.88-2.40-9.60NA
Q1 2020
5/11/2020
142.80-3.12-12.48NA
Q4 2019
3/12/2020
114.00-4.56-18.24NA
Q3 2019
11/12/2019
29.28-3.00-12.00NA
Q2 2019
8/8/2019
30.48-3.60-14.40NA
Q1 2019
5/9/2019
46.44-3.60-14.40NA
Q4 2018
3/12/2019
42.72-4.08-16.32NA
Q3 2018
11/8/2018
62.28-3.24-12.96NA
Q2 2018
8/7/2018
48.24-0.96-3.84NA
Q1 2018
5/9/2018
57.96-4.32-17.28NA
Q4 2017
3/14/2018
53.64-3.00-12.00NA
Q3 2017
11/8/2017
63.96-4.80-19.20NA
Q2 2017
8/8/2017
65.16-1.56-6.24NA
Q1 2017
5/10/2017
76.68-3.72-14.88NA
Q4 2016
3/15/2017
82.44-4.20-16.80NA
Q3 2016
11/9/2016
89.16-3.36-13.44NA
Q2 2016
8/8/2016
112.20-3.12-12.48NA
Q1 2016
5/9/2016
114.24-1.32-5.28NA
Q4 2015
3/14/2016
80.16-3.00-12.00NA
Q3 2015
11/9/2015
84.240.843.3625.1
Q2 2015
8/10/2015
98.28-1.32-5.28NA
Q1 2015
5/11/2015
96.12-2.16-8.64NA
Q4 2014
3/16/2015
101.04-1.44-5.76NA
Q3 2014
11/10/2014
134.88-1.44-5.76NA
Q2 2014
8/11/2014
107.64-2.04-8.16NA
Q1 2014
5/12/2014
104.16-0.60-2.40NA
Q4 2013
3/17/2014
164.16-0.84-3.36NA
Q3 2013
11/12/2013
84.00-1.92-7.68NA
Q2 2013
8/9/2013
92.16-0.72-2.88NA
Q1 2013
5/10/2013
29.76-0.72-2.88NA
Q4 2012
3/18/2013
25.440.000.00NA
Q3 2012
11/7/2012
32.16-0.60-2.40NA
Inovio Pharmaceuticals PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/6/2024
9.87-1.10-6.14NA
Q3 2023
11/9/2023
4.32-1.56-7.68NA
Q2 2023
8/9/2023
4.80-1.56-7.92NA
Q1 2023
5/10/2023
9.72-1.92-11.88NA
Q4 2022
3/1/2023
14.88-2.64-14.28NA
Q3 2022
11/8/2022
25.68-1.80-17.64NA
Q2 2022
8/9/2022
25.20-5.52-19.32NA
Q1 2022
5/10/2022
29.88-4.32-18.48NA
Q4 2021
3/1/2022
38.88-6.00-17.40NA
Q3 2021
11/9/2021
84.60-3.48-13.08NA
Q2 2021
8/9/2021
115.20-4.68-12.72NA
Q1 2021
5/10/2021
80.04-3.24-10.44NA
Q4 2020
3/1/2021
139.20-1.68-10.32NA
Q3 2020
11/9/2020
102.00-3.12-13.20NA
Q2 2020
8/10/2020
227.88-2.40-13.08NA
Q1 2020
5/11/2020
142.80-3.12-14.28NA
Q4 2019
3/12/2020
114.00-4.56-14.76NA
Q3 2019
11/12/2019
29.28-3.00-14.28NA
Q2 2019
8/8/2019
30.48-3.60-14.52NA
Q1 2019
5/9/2019
46.44-3.60-11.88NA
Q4 2018
3/12/2019
42.72-4.08-12.60NA
Q3 2018
11/8/2018
62.28-3.24-11.52NA
Q2 2018
8/7/2018
48.24-0.96-13.08NA
Q1 2018
5/9/2018
57.96-4.32-13.68NA
Q4 2017
3/14/2018
53.64-3.00-13.08NA
Q3 2017
11/8/2017
63.96-4.80-14.28NA
Q2 2017
8/8/2017
65.16-1.56-12.84NA
Q1 2017
5/10/2017
76.68-3.72-14.40NA
Q4 2016
3/15/2017
82.44-4.20-12.00NA
Q3 2016
11/9/2016
89.16-3.36-10.80NA
Q2 2016
8/8/2016
112.20-3.12-6.60NA
Q1 2016
5/9/2016
114.24-1.32-4.80NA
Q4 2015
3/14/2016
80.16-3.00-5.64NA
Q3 2015
11/9/2015
84.240.84-4.08NA
Q2 2015
8/10/2015
98.28-1.32-6.36NA
Q1 2015
5/11/2015
96.12-2.16-7.08NA
Q4 2014
3/16/2015
101.04-1.44-5.52NA
Q3 2014
11/10/2014
134.88-1.44-4.92NA
Q2 2014
8/11/2014
107.64-2.04-5.40NA
Q1 2014
5/12/2014
104.16-0.60-4.08NA
Q4 2013
3/17/2014
164.16-0.84-4.20NA
Q3 2013
11/12/2013
84.00-1.92-3.36NA
Q2 2013
8/9/2013
92.16-0.72-2.04NA
Q1 2013
5/10/2013
29.76-0.72NANA
Q4 2012
3/18/2013
25.440.00NANA
Q3 2012
11/7/2012
32.16-0.60NANA
Quotes delayed 20 minutes

Email EnvelopeFree INO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Inovio Pharmaceuticals (INO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

INSM PE Ratio History
INSP PE Ratio History
INTS PE Ratio History
INVA PE Ratio History
INVO PE Ratio History
INZY PE Ratio History
IOBT PE Ratio History
IONS PE Ratio History
IOVA PE Ratio History
IPSC PE Ratio History
How should the INO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Inovio Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this INO Historical PE Ratio page.

What is the average historical PE for INO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The INO historical PE ratio using the annualized quarterly earnings method works out to 25.1.

What is the average historical PE for INO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The INO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Inovio Pharmaceuticals Historical PE Ratio information for Inovio Pharmaceuticals' stock. The average INO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 25.1. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average INO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this INO historical PE result, against the recent PE: when this page was posted on 3/22/2024, the most recent closing price for INO had been 11.62, and the most recent quarterly earnings result, annualized, was 3.36. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent INO PE on 3/22/2024 based on annualized quarterly EPS was 3.5. Based on INO's history, that recent PE is low relative to the historical average, with the recent PE 86.1% lower than the historical average PE across our data set for Inovio Pharmaceuticals.

For self directed investors doing their due diligence on INO or any other given stock, valuation analysis for INO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Inovio Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for INO. Thanks for visiting, and the next time you need to research INO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: LTRX Split History, CHRA YTD Return, EYE Historical Stock Prices.

 

Inovio Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.